Insight on Pharmaceuticals and Healthcare in North America

The following industries match your search criteria:

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

Results are sorted by relevance. Click on heading titles to sort results by different field.

Type Product title / description Pub Price
Report
Report

In Vitro Diagnostics M&A and Deal Trends

This report provides an analysis of strategies and trends employed by companies operating in the in vitro diagnostics (IVDs) market in order to drive revenue growth.

Published By Datamonitor
17 Jul 2012 $2800
Buy
Report
Report

Prescribing Influences: Schizophrenia – Plethora of antipsychotics fail to address negative symptoms

This report analyzes the unmet needs of schizophrenia treatment and the attributes of drugs that influence the prescribing decisions made by physicians across the seven major markets.

Published By Datamonitor
26 Jun 2012 $2800
Buy
Report
Report

Market and Product Forecasts: Non-Insulin Antidiabetics – Incretin mimetics face off in type 2 diabetes

Datamonitor patient-based forecast of leading non-insulin brands and pipeline products for 2011 to 2020. Coverage: US, Japan, France, Germany, Italy, Spain, and the UK.

Published By Datamonitor
29 May 2012 $6400
Buy
Report
Report

R&D Trends 2012

Analysis of strategies and trends being employed by the leading pharmaceutical companies in order to overcome the ongoing R&D challenges, in addition to examining clinical pipelines and strategies to source new drugs.

Published By Datamonitor
14 May 2012 $2800
Buy
Report
Report

Case Study: Autism Spectrum Disorders – Public awareness and physician detailing will drive market growth

This report examines the opportunities and threats within the autism spectrum disorders (ASDs) market. The analysis is intended to support company strategy and decision-making by providing actionable recommendations in the current treatment pathway.

Published By Datamonitor
16 Apr 2012 $1520
Buy
Report
Report

Market and Product Forecasts: HIV – Rising prevalence and novel STRs boost sales in the US and Europe

This report provides an overview of current HIV treatments in the US and five major EU markets (France, Germany, Italy, Spain, and the UK), supported by a large physician survey, key opinion leader insight, and a patient-based forecast.

Published By Datamonitor
24 Feb 2012 $6400
Buy
Report
Report

Market and Product Forecasts: Rectal Cancer – Chemoradiation boosts cytotoxic use as new approvals add moderate value

This report and accompanying deliverable provide forecasts for rectal cancer drugs in the seven major markets over 2011–20, including in-depth analysis of the rectal cancer market in individual countries and molecule dynamics of the key therapies.

Published By Datamonitor
20 Feb 2012 $6400
Buy
Report
Report

Market and Product Forecasts: Depression – Further clinical failures dampen growth prospects

Assessment of the current and future depression market using patient-based forecasting methodology. The analysis is designed to understand the future dynamics of the depression drug market, with a particular focus on pipeline therapies.

Published By Datamonitor
19 Jan 2012 $6400
Buy
Report
Report

Product Profiles: Depression – Next generation vies for second-line patients

In-depth analysis of key brands and pipeline agents indicated for the treatment of depression. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.

Published By Datamonitor
17 Jan 2012 $6400
Buy
Report
Report

Market and Product Forecasts: Insulin Antidiabetics – Biosimilar entry not enough to stem growth of insulin analogs

Datamonitor patient-based forecast of leading insulin brands and pipeline products for 2011 to 2020. Coverage: US, Japan, France, Germany, Italy, Spain, and the UK

Published By Datamonitor
28 Dec 2011 $6400
Buy

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | » »|

No help is available.